Which Breast Cancer Treatment Should You Choose? at www.ResourcesForBreastCancer.com
ResourcesForBreastCancer.com :: Alternative Forms Of Medicine For Cancer Patient

Alternative Forms Of Medicine For Cancer Patient


Alternative forms of medicine like:

Acupuncture can be used for providing pain relief.

Herbal Medicine helps strengthen the body's ability to eliminate cancer cells. They do not however cure cancer, but can definitely prolong the life of a person suffering from cancer.

Homeopathy is effective in providing relief from the side effects of chemotherapy and radiation.

Mind and Body Treatment focuses on a persons emotions, behaviour and faith. It is believed that a person must maintain a positive attitude and live a life free of mental and emotional stress. Massage and reflexology have also been found to be effective in strengthening cells and promoting the release of anti-cancer hormones in the body. The Mind and Body treatment has been found to be very effective and powerful in dealing with cancer, and perhaps even preventing it.

Nutrition and Diet has been found to be effective in preventing tissue and cell damage and ensuring the proper immune function of the body.

Traditional Chinese Medicine has been found to be effective in providing relief from the side effects of the conventional treatments of cancer. Practitioners of this form of medicine recommend the use of herbs like Asian Ginseng, Astragalus and Dong Quai.


About the Author: Article submited By John D. Samara On the behalf of www.childcancerandyou.org. John D. Samara is a journalist and presently working in remote areas of asian sub continents for awareness on Cancer. Global cancer concern india is a ngo in india serving cancer suffering people for cure of different types of cancer like child cancer, throat cancer, breast cancer, bone cancer, prostat cancer etc. For making donations kindly visit www.childcancerandyou.org Donation for Cancer Patients , Online Donations, Donate Online for Cancer Patients, NGO india

Source: www.isnare.com

Written by: John J

Updates and Recent News

Largest Review Of Its Kind Associates Anti-Inflammatory Drugs With Reduced Breast Cancer Risk
Analysis of data from 38 studies that enrolled more than 2.7 million women the largest of its kind by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 percent relative risk reduction in breast cancer compared to non-users. A separate analysis for Aspirin showed a 13 percent relative risk reduction in breast cancer and an analysis for Advil showed a 21 percent relative risk reduction. The review, published in the U.S. Journal of the National Cancer Institute, alludes to a protective affect against breast cancer. It was conducted by Dr. Mahyar Etm.
To Read More...

Fenretinide Cuts The Risk Of Second Breast Cancers
A 15-year follow-up of women in a breast cancer trial has found that fenretinide[1] - a drug correlation to vitamin A - significantly cuts the risk of a second breast cancer among younger patients. The Italian research team reporting the findings on-line (Thursday 4 May) in Annals of Oncology[2], are sufficiently convinced of the drug's protective potential to call for a trial to test its use as a preventive in pre-menopausal healthy women at high risk of the disease. They are now seeking international partners and funding for such a trial....
To Read More...

Tamoxifen Chemoprevention Tied To Early Detection Of Breast Cancer
The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute. Women at high-risk for breast cancer who took tamoxifen as a preventive measure in a clinical trial and later developed ER-negative breast cancer had a median time to first diagnosis of 24 months, compared with 36 months for those who received placebo, according to a retrospective statistical analysis. While long-term survival has not yet been observed for the trial, that one-year advanced diagnosis is an unexpected and significant finding, said study lead author Yu Shen, Ph.D., professor in The University of Texas M. D. Anders.
To Read More...